Immunovant, Inc. — Director's Dealing 2019

Dec 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Sciences Acquisitions Corp (IMVT)
CIK: 0001764013
Period of Report: 2019-12-18

Reporting Person: Health Sciences Holdings, LLC (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-18	Warrants to purchase Common Stock	$11.50	J	10000000	Disposed		Common Stock (5000000)	Direct

Footnotes

F1: The warrants were cancelled in connection with the business combination, consummated on December 18, 2019, by and between Health Sciences Acquisitions Corporation and Immunovant Sciences, Ltd.

F2: The warrants become exercisable on May 9, 2020.

F3: The warrants expire on December 18, 2024, or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.